Searched for
DR SHAILESH AYYANGAR
Emcure Pharma files DRHP for IPOPune-based Emcure Pharmaceuticals, one of India’s biggest unlisted pharma companies, filed its draft red herring prospectus (DRHP) with the...
Emcure to soon file papers for Rs 4,000 crore IPOThe IPO will consist of a primary issue and offer for sale from its promoter Satish Mehta and existing investor Bain Capital which acquired...
Buy Sanofi, target price Rs 7,170: Dharmesh ShahDharmesh Shah recommended to keep stoploss at Rs 6650.